Annual Cash & Cash Equivalents
$8.40 M
NaN%
December 1, 2023
Summary
- As of February 24, 2025, CVKD annual cash & cash equivalents is $8.40 million
- During the last 3 years, CVKD annual cash & cash equivalents has risen by +$8.37 million (+25674.54%).
- CVKD annual cash & cash equivalents is now at all-time high.
Performance
CVKD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.36 M
-$673.30 K-13.37%
September 1, 2024
Summary
- As of February 24, 2025, CVKD quarterly cash and cash equivalents is $4.36 million, with the most recent change of -$673.30 thousand (-13.37%) on September 1, 2024.
- Over the past year, CVKD quarterly cash and cash equivalents has stayed the same.
- CVKD quarterly cash and cash equivalents is now -52.09% below its all-time high of $9.11 million, reached on September 1, 2023.
Performance
CVKD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CVKD Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10000.0% | 0.0% |
| 3 y3 years | +10000.0% | 0.0% |
| 5 y5 years | +10000.0% | 0.0% |
CVKD Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -52.1% | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -52.1% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -52.1% | >+9999.0% |
Cadrenal Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.36 M(-13.4%) |
| Jun 2024 | - | $5.04 M(-23.3%) |
| Mar 2024 | - | $6.57 M(-21.9%) |
| Dec 2023 | $8.40 M | $8.40 M(-7.8%) |
| Sep 2023 | - | $9.11 M(+182.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $3.23 M(-19.8%) |
| Mar 2023 | - | $4.03 M(>+9900.0%) |
| Dec 2022 | $32.60 K | $32.60 K(-68.4%) |
| Sep 2022 | - | $103.10 K(+73.0%) |
| Jun 2022 | - | $59.60 K |
FAQ
- What is Cadrenal Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics annual cash & cash equivalents year-on-year change?
- What is Cadrenal Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Cadrenal Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CVKD is $8.40 M
What is the all time high annual cash & cash equivalents for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high annual cash & cash equivalents is $8.40 M
What is Cadrenal Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CVKD annual cash & cash equivalents has changed by +$8.37 M (+25674.54%)
What is Cadrenal Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CVKD is $4.36 M
What is the all time high quarterly cash and cash equivalents for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high quarterly cash and cash equivalents is $9.11 M
What is Cadrenal Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CVKD quarterly cash and cash equivalents has changed by $0.00 (0.00%)